Autobio Diagnostics (SHA:603658) and subsidiary Autobio Instrument obtained two new medical device registration certificates from Henan's medical products regulator, according to a Wednesday filing with the Shanghai bourse.
The products include a multi-parameter test data management software for clinical lab data processing, and an interleukin 12p70 detection kit using magnetic particle chemiluminescence for quantitative testing in serum and plasma.
Both certificates are valid for five years.
Shares of the medical technology company closed 1% lower Thursday.